Oliver Mühlemann has been professor of biochemistry at the University of Bern (Switzerland) since 2010 and the director of the National Center of Competence in Research (NCCR) on RNA & Disease since 2014. He has been a member of the Swiss National Science Foundation’s (SNSF) research council since 2018. Together with Marc-David Ruepp, he initiated the Elucidation of Selective Motor Neuron Death in Amyotrophic Lateral Sclerosis (ALS) project.
Born in Switzerland, Mühlemann studied biology at the University of Bern and graduated with an MS in cell biology. Interested in understanding the regulation of alternative pre-mRNA splicing, he moved to Sweden to conduct his PhD research at the Karolinska Institute in Stockholm and at Uppsala University, where he graduated in 1998. After postdoctoral work with Melissa Moore at Brandeis University (Boston, US), Mühlemann returned to the University of Bern as a junior group leader in 2000 and focused on the investigation of cellular mRNA surveillance. He was awarded a starting grant from the European Research Council (ERC) in 2007 and appointed full professor in 2010.
Mühlemann’s research interests comprise different aspects of RNA biology, including questions about the origin of life, post-transcriptional regulation of gene expression and elucidation of disease mechanisms involving malfunctioning RNA processing.
Elucidation of Selective Motor Neuron Death in Amyotrophic Lateral Sclerosis (ALS)
NOMIS RESEARCH PROJECT